Company CareDx, Inc

Equities

CDNA

US14167L1035

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for CareDx, Inc

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Diagnostics & Testing

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
7.85 ^USD	-4.27%		-21.11%	-34.58%

10:57pm	CareDx Appoints John Hanna as CEO, President	MT
Apr. 09	Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	RE

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Companyâs product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Number of employees: 639

USD in Million	2022	Weight	2023	Weight	Delta
Testing Services 74.8 %	264	82.0 %	210	74.8 %	-20.50%
Patient and Digital Solutions 13.2 %	29	8.9 %	37	13.2 %	+28.92%
Product 12.0 %	29	9.1 %	34	12.0 %	+14.58%

USD in Million	2022	Weight	2023	Weight	Delta
United States 94.8 %	308	95.6 %	266	94.8 %	-13.63%
Europe 3.6 %	10	3.0 %	10	3.6 %	+6.47%
Rest of the World 1.6 %	5	1.5 %	5	1.6 %	-3.70%

Managers	Title	Age	Since
Abhishek Jain DFI	Director of Finance/CFO	48	21-07-31
Ashish Kothari CTO	Chief Tech/Sci/R&D Officer	-	-
Marica Grskovic COO	Chief Operating Officer	-	-
Robert N. Woodward CTO	Chief Tech/Sci/R&D Officer	-	-
Peter Maag BRD	Director/Board Member	56	12-09-30
Gregory Peter Chodaczek IRC	Investor Relations Contact	-	-
Kashif Rathore PRN	Corporate Officer/Principal	-	-
Ryan Phan PRN	Corporate Officer/Principal	-	-
Mickey Kim PRN	Corporate Officer/Principal	-	-
Alexander Johnson PRN	Corporate Officer/Principal	50	-

Members of the board	Title	Age	Since
William A. Hagstrom BRD	Director/Board Member	66	15-03-01
George Bickerstaff BRD	Director/Board Member	68	14-04-07
Christine Cournoyer BRD	Director/Board Member	72	19-08-26
Michael Goldberg CHM	Chairman	66	11-10-31
Fred Cohen BRD	Director/Board Member	67	02-12-31
Grace E. Colón BRD	Director/Board Member	57	19-06-30
Peter Maag BRD	Director/Board Member	56	12-09-30
Hannah Valantine BRD	Director/Board Member	72	21-06-30
Arthur A. Torres BRD	Director/Board Member	77	21-09-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	51,778,523	49,837,336 ( 96.25 %)	0	96.25 %

Name	Equities	%	Valuation
ARK Investment Management LLC 13.90 %	7,194,722	13.90 %	76 M $
BlackRock Advisors LLC 10.13 %	5,245,692	10.13 %	56 M $
Vanguard Fiduciary Trust Co. 7.956 %	4,119,682	7.956 %	44 M $
Bellevue Asset Management AG 7.638 %	3,954,792	7.638 %	42 M $
Nikko Asset Management Americas, Inc. 5.552 %	2,874,899	5.552 %	30 M $
Nikko Asset Management Americas, Inc. 5.552 %	2,874,899	5.552 %	30 M $
STATE STREET CORPORATION 5.400 %	2,796,267	5.400 %	30 M $
D.E. Shaw & Co., Inc. 4.251 %	2,201,221	4.251 %	23 M $
Gagnon Securities LLC 4.048 %	2,096,044	4.048 %	22 M $
Morgan Stanley Investment Management, Inc. 3.048 %	1,578,228	3.048 %	17 M $

CareDx, Inc.

8000 Marina Boulevard

94005, Brisbane

+415 287 2300

http://www.caredx.com

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

8.2 USD

Average target price

12.5 USD

Spread / Average Target

+52.44%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
CAREDX, INC	-34.58%	425M
EXACT SCIENCES CORPORATION	-13.68%	11.86B
IOVANCE BIOTHERAPEUTICS, INC.	+46.62%	3.32B
GUARDANT HEALTH, INC.	-40.26%	2.08B
BGI GENOMICS CO., LTD.	-18.71%	2.05B
VERACYTE, INC.	-31.23%	1.45B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+24.27%	1.07B
SEEGENE, INC.	-4.80%	723M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-43.88%	422M
CURIOX BIOSYSTEMS CO., LTD	-10.54%	260M

Bio Diagnostics & Testing